Introduction
Patients with respiratory failure frequently require endotracheal intubation and mechanical ventilation (MV) to sustain life. While invasive ventilation is effective, it has been associated with the development of complications including respiratory muscle weakness, upper airway pathology, ventilatorassociated pneumonia and sinusitis [1] . Ventilatorassociated pneumonia is in turn associated with increased morbidity and a trend toward increased mortality. For these reasons, minimizing the duration of invasive mechanical support is an important goal of critical care medicine [2] . Removal of patients from MV has been termed liberation, discontinuation, withdrawal, and most commonly weaning. The process of permanent removal of the artificial airway is extubation [3] .
A balance must be achieved between the risk associated with early discontinuation and delay in extubation. Premature withdrawal causes loss of airway protection, cardiovascular stress, suboptimal gas exchange, muscle overload, and fatigue. Delayed withdrawal exposes patients to complications associated with ventilation, such as infections, barotrauma, stretch injury, sedation, airway trauma, and costs [4] . Noninvasive ventilation (NIV) can be used to facilitate weaning (earlier extubation), to prevent reintubation in postsurgical respiratory distress, and in patients with respiratory failure after planned extubation. In the latter instance, NIV has been used immediately after extubation in patients at elevated risk for extubation failure [5] . In contrast, NIV has been applied in patients who developed overt respiratory failure after extubation, with the goal of avoiding reintubation [6] .
Aim
This work aimed to study the impact of NIV on the outcome of the extubated chronic hypercapnic patients and compare it versus conventional oxygen therapy in the Respiratory Intensive Care Unit (RICU) at Ain Shams University Specialized Hospital during the period spanning from October 2013 to May 2015.
Patients and methods
Informed consent was taken from all patients (or their legal guardians) who were invited to participate in the research as regards confidentiality, right to refuse or withdraw, and in case of refusing to participate in the research, the patient will be followed up and will receive his treatment as planned. The consent was revised and approved by the ethical committee of scientific research. This was a prospective study that was conducted upon 80 extubated chronic hypercapnic respiratory failure patients admitted to the respiratory ICU at Ain Shams University Specialized Hospital during the period spanning from October 2013 to May 2015 (18 months). Patients were subdivided into two groups:
(1) Group A: this group included 40 extubated chronic hypercapnic patients who were kept on NIV immediately after removal of the endotracheal tube. (2) Group B: it included 40 extubated chronic hypercapnic patients who were kept on conventional oxygen therapy after removal of the endotracheal tube.
Patient selection and group allocation
All the patients who were included in this study met the inclusion criteria and did not have any of the exclusion criteria. They were selected by convenience sampling strategy; thereafter, they were randomly allocated into one of the study groups.
Convenience sampling strategy
It is a type of nonprobability sampling method where the sample is taken from a group of people easy to contact or to reach. The reason that it is most often used is because of the numerous advantages it provides. This method is extremely speedy, easy, readily available, and cost effective.
Patients' randomization
The method used for patient randomization was to give each patient an enrollment number, thereafter allocating patients with odd numbers to group A and patients with even numbers to group B (i.e. first, third, etc. patients in group A and second, fourth, etc. patients in group B).
Inclusion criteria
(1) Patients with chronic hypercapnic respiratory failure just extubated from invasive MV. Patients in groups A and B were subjected to the following:
(1) Informed consent from the patients or their guardians before their enrollment in the study. Study end-points:
(1) Improvement of the patient and discharge from the RICU.
(2) Reintubation of the patient.
(3) Death.
Statistics
Data were revised, coded, tabulated, and fed into a personal computer using statistical package for the social sciences (released 2011, IBM SPSS Statistics for Windows, version 20.0; IBM Corp., Armonk, New York, USA).
Descriptive statistics
(1) Mean±SD, and range for parametric numerical data. (2) Frequency and percentage of non-numerical data.
Analytical statistics
(1) Student's t-test was used to assess the statistical significance of the difference between two study group means. (2) Analysis of variance test was used to assess the statistical significance of the difference between more than two study group means. (3) Correlation analysis was used to assess the strength of association between two quantitative variables. The correlation coefficient denoted symbolically as 'r' defines the strength and direction of the linear relationship between two variables.
(4) χ 2 -Test was used to examine the relationship between two qualitative variables. (5) Fisher's exact test was used to examine the relationship between two qualitative variables when the expected count was less than 5 in more than 20% of cells. (6) Two-tailed P value greater than 0.05 was considered insignificant; meanwhile, P less than or equal to 0.05 was considered significant.
Results
The present study included 80 extubated chronic hypercapnic respiratory failure patients who were admitted to RICU at Ain Shams University Specialized Hospital during the period spanning from October 2013 to May 2015 (Tables 1-3 ).
The present study showed a statistically significant difference between both groups with regard to the final outcome, as 75% of patients in group A were discharged from the RICU versus 42.5% of patients in group B, while 22.5% of patients in group A required reintubation versus 52.5% of patients in group B.
Moreover, the present study showed a statistically significant difference between both groups, with regard to the length of stay in the RICU after extubation, with shorter duration in group A (1.6±0.49 day) than in group B (6.13±1.79 day), as shown in Table 4 .
As regards arterial blood gas (ABG) parameters at the final outcome, the present study showed a statistically significant difference in pH value, which was higher in group A (7.36±0.05) than in group B (7.32±0.04).
There was also a statistically significant difference in PCO 2 , which was lower in group A (59.8±9.16) than in group B (68.85±7.87).
There was a statistically significant difference in PO 2 , which was higher in group A (61.05±4.76) than in group B (56.22±5.43).
Finally, there was a statistically significant difference in O 2 saturation, which was higher in group A (88.8 ±6.42) than in group B (83.47±7.51). This indicates that, group A patients had better ABG parameters at the final outcome, as shown in Table 5 .
Of the 40 patients of group A, 26 (65%) patients required FiO 2 at the final outcome of 24% versus 23 (57.5%) patients in group B who required an FiO 2 of 60%, and this was statistically significant, as shown in Table 6 , which indicates that most patients in group A required lesser FiO 2 at the final outcome than most patients in group B. Table 7 and Table 8 describe the relation between the cause of hypercapnic respiratory failure and the final outcome in group A and group B, respectively.
The current study showed that in group A, the rate of discharge of patients in RICU was as follows: 88.89% of obesity hypoventilation syndrome (OHV) patients followed by 72.73% of chronic obstructive pulmonary disease (COPD) patients, while in group B, 50% of interstitial lung disease (ILD) patients were discharged from the RICU followed by 43.47% of COPD patients. This confirms that patients with OHV had the most significant benefit from the use of NIV after extubation.
In addition to this, the current study showed that there was a statistically significant relation between the cause of hypercapnic respiratory failure and the ABG parameters at the final outcome of patients in both groups, as shown in Table 9 .
In patients with COPD, there was a statistically significant difference between both groups with regard to pH, PCO 2 , PO 2 , and O 2 saturation, with the better values being achieved in group A.
In patients with ILD, there was a statistically significant difference between both groups only in PO 2 in favor of group A. In patients with OHV, there was a statistically significant difference between both groups with regard to pH, PCO 2 , PO 2 , and O 2 saturation, with the better values obtained in patients of group A.
The results of the current study showed that there was a statistically significant difference between both groups, with regard to causes of reintubation, as shown in Tables 10 and 11 . The main causes in group A were worsening of hypercapnia in 100% and lack of patients' compliance in 77.8%, in the nine patients who required reintubation in this group, while in group B, the main cause was persistent hypoxia (95.2%) and worsening of hypercapnia (90.5%).
Discussion
In In the present study, the cause of hypercapnic respiratory failure in group A was COPD, with acute exacerbation (AE) in 22 (55%) patients, ILD with AE in nine (22.5%) patients and OHS in nine (22.5%) patients, while in group B, 23 (57.5%) patients suffered COPD with AE, six (15%) patients were suffering from ILD with AE, 10 (25%) patients were suffering OHS and one (2.5%) patient suffered myasthenia gravis. This is not the same in the trial of Myasthenia gravis (n=1) 0 (0) 1 (100) 0 (0) COPD, chronic obstructive pulmonary disease; ILD, interstitial lung disease; OHV, obesity hypoventilation syndrome. Ornico et al. [7] , wherein the most common cause of respiratory failure was pneumonia in 88 and 88.9%, respectively, in both groups, followed by COPD in 35 and 16.7%, respectively, in both groups. This difference can be attributed to including patients with acute respiratory failure together with patients with acute-on-chronic respiratory failure, while in the current study, we included patients with chronic hypercapnic respiratory failure. Moreover, this is not matching the data from Ferrer et al. [8] , who found that the causes of hypercapnic respiratory failure in the NIV group patients were COPD in 38 (70%) patients, sequelae of pulmonary tuberculosis in seven (13%) patients, bronchiectasis in two (4%) patients, followed by OHV in five (9%) patients, whereas in patients of conventional oxygen therapy group, the causes were COPD in 36 (69%) patients, sequelae of pulmonary tuberculosis in six (12%) patients, bronchiectasis in four (8%) patients, OHV in four (8%) patients, and chest-wall deformity in one (2%) patient. The difference in the data may be related to the larger number of patients and exclusion of ILD patients, while in the current study, patients were selected by convenience sampling strategy; thereafter, they were randomly allocated to one of the study groups.
In the present study, it was found that there was a statistically significant difference between both groups with regard to the required FiO 2 at the final outcome with 65% of patients in group A requiring an FiO 2 of 24% versus 57.5% of patients in group B requiring an FiO 2 of 60%. This confirms the beneficial effect of NIV when applied immediately after extubation on the required FiO 2 at the final outcome of patients with chronic hypercapnic respiratory failure.
As regards ABG parameters at the final outcome, the present study showed a statistically significant difference in pH, which was higher in group A (7.36±0.05) than in group B (7.32±0.04), a statistically significant difference in PCO 2 , which was lower in group A (59.8±9.16) than in group B (68.85±7.87). There was a statistically significant difference in PO 2 , which was higher in group A (61.05 ±4.76) than in group B (56.22±5.43). Moreover, there was a statistically significant difference in O 2 saturation, which was higher in group A (88.8±6.42) than in group B (83.47±7.51). This is matching the results found by Hilbert et al. [9] , who established a statistically significant difference in ABG parameters at the final outcome of 60 COPD patients (divided into two groups receiving NIV after extubation and conventional oxygen therapy, respectively) with a mean pH (±SD) of 7.39±0.05 in the NIV group, which is higher than the other group (7.33±0.04), mean PCO 2 (±SD) was 57.75±8.25 in the NIV group, which is lower than that of the other group (69±6.75), and mean PO 2 of 76.5±9.75 in the NIV group, which was higher than that of the other group (60±11.25). Furthermore, our results were matching the results of Ornico et al. [7] , who assessed the ABG of patients in both groups after extubation and found that patients in the NIV group had a higher PO 2 , lower PCO 2 , respiratory rate, and mean blood pressure compared with patients in the conventional oxygen therapy group.
The present study showed a statistically significant difference between both groups with regard to the final outcome, as 75% of patients in group A were discharged from the RICU versus 42.5% of patients in group B, whereas 22.5% of patients in group A required reintubation versus 52.5% in patients in group B. In the study conducted by Ferrer et al. [8] , there were matching results to the current study, as it was found that, in patients of the NIV group, 85% were discharged from the ICU versus 52% in the conventional oxygen therapy group patients. Moreover, they found that patients who developed respiratory failure after extubation in both groups were 15 versus 48%, respectively [7] ; furthermore, showing a statistically significant difference between both groups with regard to the final outcome, with 95% in NIV being discharged from ICU versus 61% in the conventional oxygen group, and reintubation was required in 5% in the NIV group versus 39% in the other group. They demonstrated that the major cause for the high success rate in the NIV group was the early application of the NIV immediately after the planned extubation.
In contrast, Esteban et al. [10] , found no statistically significant difference between both groups with regard to the final outcome, as 48% of patients in both groups required MV. They demonstrated that the reasons for these results were lacking the experience of the health care team using NIV, the composition of the study sample population may have influenced the results (only 10% of patients had COPD), and, finally, the timing of the initiation of NIV could be important (noninvasive positive-pressure ventilation after extubation should be initiated early, before the development of signs of respiratory failure).
In the present study, there was a statistically significant difference between both groups with regard to causes of reintubation, as the main causes in group A were worsening of hypercapnia (100%) and lack of patients' compliance (77.8%) in patients requiring reintubation in this group, while in group B, the main cause was persistent hypoxia (95.2%) and worsening of hypercapnia (90.5%). This matches the results of Ferrer et al. [8] , who found that the main cause of postextubation respiratory failure in both groups was worsening of hypercapnia and persistent hypoxia in 37.5 and 72%, respectively. They excluded lack of patients' compliance as a cause of reintubation. Similar results were found by Ornico et al. [7] with regard to the causes of reintubation, adding the inability to expectorate sputum to the reintubated patient in the NIV group. In contrast, Esteban et al. [10] , found that the main cause of reintubation in their trial was lack of improvement in signs of muscle fatigue in 45% of patients of both groups, followed by persistent hypoxia in 16 and 29% of both groups, respectively.
As regards the length of stay in the RICU (in days) after extubation, the present study showed a statistically significant difference between both groups, with shorter duration in group A (1.6±0.49) than in group B (6.13±1.79). This is in accordance with the results of El Solh et al. [11] , who conducted a trial on 62 morbidly obese extubated patients receiving NIV and a matching group receiving conventional oxygen therapy; they found a statistically significant difference with regard to the length of stay in the ICU after extubation, with mean length (±SD) of 11.8±7.9 and 18.2±11.2, respectively. Moreover, this is matching the results of Hilbert et al. [9] , who found that the length of stay in the ICU after extubation in COPD patients receiving NIV after extubation was statistically shorter than that of COPD patients receiving the standard medical therapy with mean length (±SD) of 8±4 and 14 ±8 days, respectively.
In contrast, the current results did not match the results of Ferrer et al. [8] , who showed no statistically significant difference between both groups with regard to the length of stay in the ICU after extubation, with mean length (±SD) of 11±13 and 10±9 days, respectively. This contradiction may be due to the larger number of patients and conducting their study in multiple ICUs. Moreover, the current data did not match those of Ornico et al. [7] , who showed comparable length of stay in the ICU after extubation in both groups, with mean length (±SD) of 16.8±11.6 and 18.4±12.2 days, respectively.
In both groups of the current study, there was no statistically significant relation between the cause of chronic hypercapnic respiratory failure and the final outcome, but, in group A, 88.89% of OHV patients were discharged from the RICU followed by 72.73% of COPD patients, while in group B, 50% of ILD patients were discharged from the RICU, followed by 43.47% of COPD patients. This confirms that patients with OHV had the most significant benefit from the use of NIV after extubation, but, because of the small sample size, no statistically significant relation could be established. This matches the results of the clinical trial conducted by El Solh et al. [11] , who found that in 62 morbidly obese extubated patients who received NIV after extubation, 90% were discharged from ICU versus 10% who required reintubation, while in a matching group receiving conventional oxygen therapy, only 79% of patients were discharged from ICU versus 21% who required reintubation. Moreover, the current results match those of Hilbert et al. [9] , who demonstrated that 20% of COPD patients receiving NIV after extubation required reintubation versus 67% of COPD patients receiving conventional oxygen therapy after extubation.
In the present study, there was a statistically significant relation between the cause of hypercapnic respiratory failure and the ABG parameters at the final outcome of patients in both groups. In patients with COPD, there was a statistically significant difference between both groups with regard to pH, PCO 2 , PO 2 , and O 2 saturation, with better values in patients of group A. In patients with ILD, there was a statistically significant difference between both groups only in PO 2 , with mean value±SD of 61.44±3.08 in group A versus 55.5±6.53 in group B. In patients with OHV, there was a statistically significant difference between both groups with regard to pH, PCO 2 , PO 2 , and O 2 saturation, with better values in patients of group A.
Conclusion
Application of NIV in patients with chronic hypercapnic respiratory failure immediately after extubation had decreased the rate of reintubation, shortened the length of ICU stay and improved their final outcome (as indicated by improving ABG parameters and decreasing the required FiO 2 ); hence, it should be integrated in the management protocols of RICU.
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